Wellnex Life Ltd (ASX: WNX) Share Price and News

Price

$0.285

Movement

0.035 (+14.0%)

as at 7 May - Closed (20 mins delayed)

52 Week Range

$0.24 - $1.45

 
1 Year Return

-65.06%

Wellnex Life Ltd Chart and Price Data

2025
2025
2025
2025
$0.00
$0.50
$1.00
$0.00
$0.50
$1.00
$0.00
$0.50
$1.00
$0.00
$0.50
$1.00

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $16.78 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 67.13 million
Earnings per share -0.164
Dividend per share N/A
Year To Date Return -51.52%
Earnings Yield N/A
Franking -
Share Price

$0.285

Day Change

0.035 (+14.0%)

52 Week Range

$0.24 - $1.45

Yesterday's Close

$0.25

Today's Open

$0.245

Days Range

$0.245 - $0.285

Volume

99,992

Avg. Volume (1 month)

107,986

Turnover

$25,588

as at 7 May - Closed

Wellnex Life Ltd (ASX: WNX)
Latest News

a woman
Mergers & Acquisitions

How to ride the ASX infant formula boom in 2020

Chinese demand has driven the share prices of several big-name ASX infant formula companies like A2 Milk Company Ltd (ASX: A2M)…

Read more »

a woman
Share Gainers

Why Appen, Brickworks, Soul Pattinson, & Wattle Health stormed higher today

The Appen Ltd (ASX:APX) share price and the Brickworks Limited (ASX:BKW) share price are two of four storming higher today...

Read more »

a woman
Share Gainers

Why Alcidion, Helloworld, Nearmap, & Wattle Health shares surged higher today

The Helloworld Travel Ltd (ASX:HLO) share price and the Nearmap Ltd (ASX:NEA) share price are two of four surging notably…

Read more »

a woman
Share Market News

Is the Bellamy's takeover a signal to invest in infant formula?

Yesterday, Bellamy’s Australia Ltd (ASX: BAL) received a takeover bid at a price of $13.25 per share. Is now the…

Read more »

a woman
52-Week Lows

The Wattle Health share price is down 60% in 2019 and at a two-year low

The Wattle Health Australia Ltd (ASX:WHA) share price has fallen significantly in 2019. Is this a buying opportunity?

Read more »

a woman
Share Gainers

Wattle Health share price on watch after acquisition update

The Wattle Health Australia Ltd (ASX: WHA) share price is on watch after the company provided an update on its…

Read more »

a woman
Share Market News

Wattle Health share price could fall on quarterly cash outflows, low sales

The Wattle Health Australia Ltd (ASX: WHA) share price could fall in early trade after the baby formula company provided…

Read more »

a woman
Share Market News

A2 Milk share price hits new 52-week high – can it surge higher in 2019?

Despite opening trade on a new record high of $17.25 this morning, can the A2 Milk Company Ltd (ASX: A2M)…

Read more »

a woman
Growth Shares

Has the A2 Milk share price growth capped out in 2019?

The A2 Milk Company Ltd (ASX: A2M) share price has surged a whopping 2,755% higher since its April 2015 IPO…

Read more »

a woman
Share Fallers

Why CIMIC, Superloop, Syrah, & Wattle Health shares tumbled lower today

The CIMIC Group Ltd (ASX:CIM) share price and the Superloop Ltd (ASX:SLC) share price are two of four tumbling notably lower on Thursday.…

Read more »

a woman
Share Market News

Why the Wattle Health share price could fall today

The Wattle Health Australia Ltd (ASX: WHA) share price could be set to fall this morning after announcing the commencement…

Read more »

a woman
Share Gainers

Why Australian Ethical, Bapcor, Western Areas, & Wattle Health shares stormed higher

The Bapcor Ltd (ASX:BAP) share price and the Western Areas Ltd (ASX:WSA) share price are two of four storming notably…

Read more »

WNX ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
6th May 2025 2025-05-06T09:09:52 Final Director's Interest NoticeYesNo9:09am2134k
6th May 2025 2025-05-06T08:42:11 Board and Management ChangesYesNo8:42am2140k
14th Apr 2025 2025-04-14T17:12:00 Becoming a substantial holderYesNo5:12pm3153k
10th Apr 2025 2025-04-10T08:54:59 Appointment of Powermed Plus as UK DistributorYesNo8:54am2140k
8th Apr 2025 2025-04-08T09:49:06 Appendix 4C and Quarterly Report for Mar 2025 QuarterYesNo9:49am7381k
1st Apr 2025 2025-04-01T17:26:42 Ceasing to be a substantial holderYesNo5:26pm3155k
1st Apr 2025 2025-04-01T16:51:22 Change in substantial holdingYesNo4:51pm5867k
31st Mar 2025 2025-03-31T10:29:54 Application for quotation of securities - WNXYesNo10:29am616k
28th Mar 2025 2025-03-28T17:00:59 Becoming a substantial holderYesNo5:00pm5178k
25th Mar 2025 2025-03-25T09:34:53 Cleansing NoticeYesNo9:34am148k

About Wellnex Life Ltd

Wellnex Life Ltd. engages in the provision of health and wellness products. It specializes on production of dairy products focuses on infant formula and dried dairy goods. The company was founded by Lazarus Karasavvidis and Martin Glenister on May 6, 2011 and is headquartered in Port Melbourne, Australia.

WNX Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
06 May 2025 $0.25 $-0.04 -13.79% 265,185 $0.29 $0.29 $0.24
05 May 2025 $0.29 $-0.01 -3.33% 35,398 $0.30 $0.30 $0.29
02 May 2025 $0.30 $-0.02 -6.25% 209,585 $0.32 $0.32 $0.29
01 May 2025 $0.32 $0.01 3.17% 121,957 $0.32 $0.32 $0.30
30 Apr 2025 $0.32 $-0.01 -3.08% 3,530 $0.32 $0.33 $0.32
29 Apr 2025 $0.33 $0.01 3.13% 160,592 $0.32 $0.33 $0.32
28 Apr 2025 $0.32 $-0.02 -5.88% 25,030 $0.33 $0.33 $0.32
24 Apr 2025 $0.34 $-0.03 -8.22% 21,915 $0.35 $0.35 $0.33
23 Apr 2025 $0.37 $0.06 19.35% 102,608 $0.31 $0.37 $0.31
22 Apr 2025 $0.31 $0.02 6.90% 31,850 $0.31 $0.31 $0.30
17 Apr 2025 $0.29 $-0.05 -14.71% 106,171 $0.30 $0.30 $0.29
16 Apr 2025 $0.34 $0.02 6.15% 53,597 $0.33 $0.34 $0.30
15 Apr 2025 $0.33 $-0.01 -3.03% 57,822 $0.32 $0.33 $0.31
14 Apr 2025 $0.33 $-0.01 -2.94% 40,349 $0.33 $0.35 $0.33
11 Apr 2025 $0.34 $0.00 0.00% 28,326 $0.35 $0.35 $0.33
10 Apr 2025 $0.35 $0.05 16.95% 127,967 $0.34 $0.35 $0.32
09 Apr 2025 $0.30 $-0.01 -3.33% 129,399 $0.34 $0.35 $0.29
08 Apr 2025 $0.30 $0.04 15.38% 195,365 $0.27 $0.31 $0.27

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
05 Mar 2025 George Karafotias Issued 68,064 $44,242
Rights issue.
05 Mar 2025 Zlatko (Zack) Bozinovski Issued 184,615 $120,000
Rights issue.
05 Mar 2025 Jeffrey Yeh Issued 1,999,999 $1,300,000
Rights issue.
07 Feb 2025 Jeffrey Yeh Issued 871,429 $697,143
Issue of securities. Deemed Issue
23 Dec 2024 Jeffrey Yeh Issued 200,000 $280,000
Issue of securities. No cash consideration
Deemed Issue
17 Oct 2024 George Karafotias Buy 5,000 $4,420
On-market trade. .
16 Sep 2024 Zlatko (Zack) Bozinovski Buy 1,190,593 $25,002
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Eric Jiang Non-Executive Director Sep 2016
Mr Jiang has over 15 years' experience and is an adviser to companies involved in trade between Australia and China. Eric brings understanding of the cultural, economic and strategic context in which Australian businesses engage with China.
Mr George Karafotias Chief Financial OfficerExecutive Director Nov 2020
Mr Karafotias has held roles in public companies over the last 9 years and has previously provided corporate advisory services to listed and unlisted companies, focusing on restructuring and refinancing.
Mr George Tambassis Non-Executive Director Sep 2024
--
Mr Zlatko (Zack) Bozinovski Chief Strategy OfficerExecutive Director Jul 2021
Mr Bozinovski is executive in the Australian retail industry with over 35 years' experience within FMCG and Pharmaceuticals companies in Australia and internationally. Mr Bozinovski co-founded Voost and has previously held senior positions at Uncle Tobys/Goodman Fielder, Pepsi Co and Sigma Pharmaceuticals.
Mr Andrew Vidler Non-Executive Director Jan 2024
Mr Vidler has experience across retail, consumer health products and retail pharmacy. Andrew in his over 30 years' experience includes nearly 20 years with the EBOS Group (formerly FH Faulding, Mayne Group and Symbion), where across roles he led the Terry White and Chemmart pharmacy brands and the Endeavour consumer health products business.
Mr Jeffrey Yeh Non-Executive Director Jan 2024
Mr Yeh is an experienced all-rounded entrepreneur, with over 21 years' experience in all aspects of pharmaceutical sales, marketing, production, quality assurance, operations, logistics, finance and management.
Mr Ruari McGirr Non-Executive Director Mar 2025
--
Mr Yuan (Vivenne) Zhang Non-Executive Director Mar 2025
--
Mr Zheng (Kobe) Li Company Secretary Jan 2019
-
Zheng (Kobe) Li Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Homart Group Pty Ltd 83,508,573 5.96%
Kobella Holdings Pty Ltd (The Kobella Holding Unit A/C) 68,571,428 4.89%
Jysf Management Pty Ltd (Jysf A/C) 65,729,522 4.69%
Kirby Superannuation Pty Ltd (Kirby Super Fund A/C) 40,154,760 2.86%
Ggp Investments Pty Ltd (Ggp Superannuation Fund A/C) 32,732,760 2.33%
Citicorp Nominees Pty Limited 32,661,975 2.33%
Gleneagle Securities Nominees Pty Limited 32,142,855 2.29%
HSBC Custody Nominees (Australia) Limited 30,559,496 2.18%
Morrison Securities Pty Ltd (Placements A/C) 28,836,995 2.06%
Zjl Pty Ltd (The Bozinovski Family A/C) 24,142,857 1.72%
18120 Pty Ltd (Hmej A/C) 22,657,143 1.62%
Lotus Capital Group Pty Ltd 19,882,100 1.42%
Gleneagle Securities (Aust) Pty Ltd 19,700,000 1.41%
Pear Management Pty Ltd 19,603,863 1.40%
Reid Jon Zulpo (Rj & Mc Zulpo Family A/C) 19,021,740 1.36%
Cw Retail Holdings Pty Ltd (Cw Retail Holdings A/C) 18,869,792 1.35%
Wattle Trading Pty Ltd 18,831,453 1.34%
Onslow Management Services Pty Ltd Ltd (Esperance A/C) 17,857,143 1.27%
Monex Boom Securities (Hk) Ltd (Clients Account) 17,750,302 1.27%
Mrs Jieni Jeffrey 16,669,265 1.19%

Profile

since

Note